Reaction

Pneumocystis Jirovecii Infection reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 1,138 reports · 69 co-occurring drugs

As of the last recalculation, Pneumocystis Jirovecii Infection appears in 1,138 FAERS reports alongside 69 co-occurring drug terms. The strongest observed disproportionality signal is ATOVAQUONE (PRR 55.7).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Atovaquone	24	55.7	55.8
Ganciclovir	27	49.4	49.5
Valganciclovir Hydrochloride Powder,	32	49.3	49.5
Ganciclovir Sodium	27	47.8	47.9
Voriconazole Injection	54	47.7	47.8
Everolimus Tablets	35	39.4	39.4
Tacrolimus Ointment 0.1%	208	37.2	37.2
Valganciclovir	37	37.1	37.1
Valganciclovir Hydrochloride	37	37.1	37.1
Tacrolimus Extended-Release Capsules	208	37.1	37.1
Voriconazole	55	34.7	34.8
Mycophenolate Mofetil	203	33.1	33.1
Mycophenolate Mofetil Hydrochloride	203	33.0	33.0
Tacrolimus	218	31.3	31.3
Basiliximab	19	30.0	30.1
Calcitriol Capsules 0.25 Mcg	32	30.0	30.1
Calcitriol Capsules 0.5 Mcg	32	30.0	30.1
Calcitriol	32	29.7	29.7
Brentuximab Vedotin	15	27.1	27.1
Bendamustine Hcl	22	26.4	26.5
Rituximab	234	25.2	25.3
Anti-Thymocyte Globulin (Rabbit)	11	25.2	25.2
Clindamycin	36	23.9	23.9
Pravastatin Sodium	24	22.6	22.7
Thiotepa	11	21.3	21.3
Methylprednisolone	140	21.0	21.0
Ceftriaxone Sodium	42	20.8	20.8
Amphotericin B	14	20.7	20.7
Clindamycin Phosphate	36	20.3	20.3
Prednisolone	171	20.2	20.2
Prednisolone Oral	171	20.2	20.2
Prednisolone Oral Solution	171	20.2	20.2
Fam-Trastuzumab Deruxtecan-Nxki	11	20.1	20.2
Bleomycin Sulfate	11	19.7	19.7
Sirolimus	14	19.2	19.2
Oseltamivir	8	18.5	18.5
Cyclophosphamide Injection, Solution	154	18.2	18.3
Cyclophosphamide	154	18.2	18.3
Cyclophosphamide For Injection	154	18.2	18.3
Doxorubicin	82	18.1	18.1
Candesartan Cilexetil	24	17.0	17.0
Obinutuzumab	15	16.9	16.9
Thiamine Hydrochloride	11	16.3	16.3
Cefepime	12	15.5	15.5
Ceftriaxone	26	14.8	14.8
Meropenem	25	14.5	14.6
Cefepime Hydrochloride	12	13.8	13.8
Everolimus	36	13.3	13.3
Fludarabine Phosphate	28	13.3	13.3
Piperacillin And Tazobactam	9	13.0	13.0
Piperacillin Sodium,Tazobactam Sodium	17	11.9	11.9
Pyrazinamide	6	11.7	11.7
Mercaptopurine	11	11.7	11.7
Mycophenilic Acid	13	11.6	11.6
Tofacitinib Citrate	8	11.2	11.2
Anakinra	10	11.1	11.1
Remdesivir	8	11.1	11.1
Amikacin	10	10.8	10.8
Busulfan	9	10.5	10.5
Ifosfamide	12	10.3	10.3
Doxorubicin Hydrochloride	18	10.2	10.2
Rifampin	8	10.1	10.1
Benralizumab	10	9.2	9.2
Vincristine Sulfate	14	8.8	8.8
Etoposide	32	8.2	8.2
Azacitidine For	8	8.1	8.1
Bortezomib	37	7.8	7.8
Daratumumab	13	6.0	6.0
Venetoclax	18	5.4	5.4

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.